Gland Pharma shares gain up to 3% after USFDA closes inspection at Visakhapatnam unit

Earlier this month, Gland Pharma secured USFDA approval for Angiotensin II Acetate injection, 2.5 mg/mL, which is used for treating blood pressure in adults with septic or other distributive shock.

Leave a Reply

Your email address will not be published. Required fields are marked *